Résumé : X-ray diffraction studies reveal the structure of {[(1,7-C2B10H11-1-COO)Bu2Sn]2O}12 to be analogous to most other {[RCOO)Bu2Sn]2)O}2 compounds. The dimer features a central Bu4Sn2O2 unit with the two Bu2Sn groups being linked via bridging oxygen atoms, each of which also carries an exocyclic Bu2Sn moiety. The two pairs of exo- and endo-cyclic tin atoms are each linked via a symmetrically bridging carboxylate ligand and the two remaining ligands coordinate the exocyclic tin atom only, in the monodentate mode. The in vitro anti-tumour activity of this compound, against a variety of cell lines, is compared with those of clinically used compounds. ? 1995.